FilingSEC EDGAR8-K
Outset Medical Reports Q3 Revenue Growth and Reduced Net Loss
· SEC accepted
StageEarnings Release
Filing content
Q3 revenue grew 14% YoY to $33.6 million with gross margin expanding to 40.7%. Net loss narrowed to $14.7 million compared to $17.8 million in the prior-year period.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…